Search Results - "Locher, Clara"
-
1
A survey of biomedical journals to detect editorial bias and nepotistic behavior
Published in PLoS biology (01-11-2021)“…Alongside the growing concerns regarding predatory journal growth, other questionable editorial practices have gained visibility recently. Among them, we…”
Get full text
Journal Article -
2
Data-sharing and re-analysis for main studies assessed by the European Medicines Agency-a cross-sectional study on European Public Assessment Reports
Published in BMC medicine (20-05-2022)“…Transparency and reproducibility are expected to be normative practices in clinical trials used for decision-making on marketing authorisations for new…”
Get full text
Journal Article -
3
An Immunosurveillance Mechanism Controls Cancer Cell Ploidy
Published in Science (American Association for the Advancement of Science) (28-09-2012)“…Cancer cells accommodate multiple genetic and epigenetic alterations that initially activate intrinsic (cell-autonomous) and extrinsic (immune-mediated)…”
Get full text
Journal Article -
4
Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
Published in Cancer research (Chicago, Ill.) (15-06-2013)“…Cancer immunosurveillance relies on effector/memory tumor-infiltrating CD8(+) T cells with a T-helper cell 1 (TH1) profile. Evidence for a natural killer (NK)…”
Get full text
Journal Article -
5
Correction: A survey of biomedical journals to detect editorial bias and nepotistic behavior
Published in PLoS biology (01-01-2022)“…[This corrects the article DOI: 10.1371/journal.pbio.3001133.]…”
Get full text
Journal Article -
6
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer
Published in Autophagy (03-10-2015)“…In spite of adjuvant chemotherapy, a significant fraction of patients with localized breast cancer (BC) relapse after optimal treatment. We determined the…”
Get full text
Journal Article -
7
The dendritic cell–tumor cross-talk in cancer
Published in Current opinion in immunology (01-02-2011)“…The question as to whether the tumor grows because of or despite the host immune system is being progressively addressed with refined technology, gene…”
Get full text
Journal Article -
8
Reporting of interventional clinical trial results in an academic center: a survey of completed studies
Published in BMC medical research methodology (22-04-2024)“…The dissemination of clinical trial results is an important scientific and ethical endeavour. This survey of completed interventional studies in a French…”
Get full text
Journal Article -
9
Tivozanib in renal cell carcinoma: a systematic review of the evidence and its dissemination in the scientific literature
Published in BMC cancer (09-04-2022)“…Tivozanib (Fotivda) is an anti-angiogenic tyrosine kinase inhibitor that was denied access to the US market by the Food and Drug Administration (FDA). In…”
Get full text
Journal Article -
10
Chemotherapy and radiotherapy: Cryptic anticancer vaccines
Published in Seminars in immunology (01-06-2010)“…Abstract An attractive, yet hitherto unproven concept predicts that the promotion of tumor regression should elicit the host's immune response against residual…”
Get full text
Journal Article -
11
How to improve the immunogenicity of chemotherapy and radiotherapy
Published in Cancer and metastasis reviews (01-03-2011)“…Chemotherapy or radiotherapy could induce various tumor cell death modalities, releasing tumor-derived antigen as well as danger signals that could either be…”
Get full text
Journal Article -
12
Outcome of patients treated with molecular adsorbent recirculating system albumin dialysis: A national multicenter study
Published in JGH open (01-08-2020)“…Background and Aim The molecular adsorbent recirculating system (MARS) is the most widely used device to treat liver failure. Nevertheless, data from…”
Get full text
Journal Article -
13
Upstream ORF affects MYCN translation depending on exon 1b alternative splicing
Published in BMC cancer (17-12-2009)“…The MYCN gene is transcribed into two major mRNAs: one full-length (MYCN) and one exon 1b-spliced (MYCNDelta1b) mRNA. But nothing is known about their…”
Get full text
Journal Article -
14
Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta‐analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate
Published in Addiction (Abingdon, England) (01-02-2018)“…Background and Aims Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders (AUDs) is an emerging concept. Our…”
Get full text
Journal Article -
15
Simultaneous Versus Delayed Resection for Initially Resectable Synchronous Colorectal Cancer Liver Metastases: A Prospective, Open-label, Randomized, Controlled Trial
Published in Annals of surgery (01-01-2021)“…OBJECTIVE:To answer whether synchronous colorectal cancer liver metastases (SLM) should be resected simultaneously with primary cancer or should be delayed…”
Get full text
Journal Article -
16
Making data sharing the norm in medical research
Published in BMJ (Online) (11-07-2023)Get more information
Journal Article -
17
Replication of systematic reviews: is it to the benefit or detriment of methodological quality?
Published in Journal of clinical epidemiology (01-10-2023)“…To perform an overview of the overlap of systematic reviews (SRs) assessing direct oral anticoagulants and characterize these reviews in terms of bias and…”
Get full text
Journal Article -
18
Crosstalk between ER stress and immunogenic cell death
Published in Cytokine & growth factor reviews (01-08-2013)“…Abstract Preclinical and clinical findings suggest that tumor-specific immune responses may be responsible – at least in part – for the clinical success of…”
Get full text
Journal Article -
19
The evidence base of US Food and Drug Administration approvals of novel cancer therapies from 2000 to 2020
Published in International journal of cancer (15-06-2023)“…Concerns have been raised that regulatory programs to accelerate approval of cancer drugs in cancer may increase uncertainty about benefits and harms for…”
Get full text
Journal Article -
20
Clinical trials during pandemics and beyond: time for a more efficient pharmacological strategy
Published in Journal of antimicrobial chemotherapy (12-08-2021)“…Abstract During the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, clinical trials on antiviral or symptomatic drugs have been…”
Get full text
Journal Article